Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue

Lung Cancer Clinical Trial

Official title:

Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue: Find Lung Cancer Stem Cells and Test Its Chemotherapy Drug Resistance; Compare Stroma Cell Between Tumor Part and Surrounding Part

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01058811
• Other study ID #: 200912012R
• Status: Recruiting
• Phase: N/A
• First received: January 27, 2010
• Last updated: January 27, 2010
• Start date: December 2009
• Est. completion date: December 2010

Study information

• Verified date: January 2010
• Source: National Taiwan University Hospital
• Contact: Chao-Chi Ho, MD PhD
• Phone: +886-2-23123456
• Email: ccho1203[@]ntu.edu.tw
• Is FDA regulated: No
• Health authority: Taiwan: Department of Health
• Study type: Observational

Clinical Trial Summary

Try to find lung cancer stem cells from primary culture of routine surgical resection of lung cancer tissue including cancer cells and stroma cells, then characterization the established cell lines, and compare the difference of stroma cells between tumor part and surrounding part.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: December 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• lung cancer patient with surgical resection of lung tumor

Exclusion Criteria:

• lung cancer patient without surgical resection of lung tumor

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
Taiwan	National Taiwan University Hospital	Taipei

Sponsors (3)

Lead Sponsor	Collaborator
National Taiwan University Hospital	Department of Health, Executive Yuan, R.O.C. (Taiwan), National Science Council, Taiwan

Country where clinical trial is conducted

Taiwan,